Brexit Roundtable: Clinical Development

Brexit Roundtable: Clinical Development
Pharmaceutical Clinical Development/EU Clinical Trials Regulation – A Dire Need for Headache Pills! This is the third in a series of three Roundtable meetings to help our members prepare for Brexit. Focused on the biggest challenges for regulatory professionals, the meetings offer an opportunity to discuss the latest information and solutions for the many challenges you face.



ONLINE BOOKING HAS NOW CLOSED - PLEASE EMAIL MEETINGS@TOPRA.ORG TO REGISTER



Brexit Roundtable: The UK exit from the EU will come into force in Q2 2019. The EU Regulation for Clinical will be enforced from 2019. What a headache in prospect!

  

When: 19 July 2018, 13.30-18.30

Where: TOPRA, 6th Floor, 3 Harbour Exchange, South Quay, London, E14 9GE, United Kingdom 

The point of view from pertinent stakeholders, followed by workshop and a panel discussion about your perspectives and open questions ready for “B-Day” and beyond.

Speakers include:
  • Nick Sykes, Pfizer
  • Rose-Marie Swallow, Bayer
  • Zoe Martin, Cancer UK
  • Simon Morgan, Pfizer

How do I apply? 

Simply log in or create an account and register below. 

Course fees:
Type Member  Non-member 
Standard                   £150+VAT                 £250+VAT                          

 

Terms and conditions 

Please read the training terms and conditions before booking this course. By booking a place on this course you are agreeing to the training terms and conditions.



When
19/07/2018 13:30 - 18:30
Where
TOPRA 6th Floor 3 Harbour Exchange Square London E14 9GE UNITED KINGDOM
Registration not available.
Your VAT country
Your Vat number
NOTE
If your company VAT number does not appear here or you would like to be invoiced using a different VAT number please email finance@topra.org

Book this course!

Our policy on photography and video

On occasions, TOPRA takes photographs and videos which may be used to help promote our conferences and courses (both online and in print). By purchasing a ticket to attend this meeting you are confirming that you are aware of this and have no objections to your image or voice appearing in any material issued by TOPRA after the meeting.

However, if for any reason you do not wish TOPRA to use your image or voice please let us know

Recording and photography by delegates is not permitted.